Cleveland Clinic is partnering with San Francisco-based Piramidal to test the world’s first artificial intelligence model trained to read brainwaves.
The AI tool can scan a day’s worth of electroencephalogram data within seconds — a process that currently takes specialists hours — to help clinicians detect seizures, strokes or brain injuries sooner, according to an Aug. 10 news release.
The technology will launch in Cleveland Clinic’s neurological intensive care units as part of the health system’s $1 billion Neurological Institute. Physicians describe the software as an “AI co-pilot” that augments, rather than replaces, neurologists.
The rollout will include multiple phases of testing, validation and refinement, with a long-term goal of making the tool available in more general healthcare settings.
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
